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Abstract
Retrovirology has been publishing as an Open Access online journal for approximately six months.
In this editorial, I review the reasons for and the advantages of Open Access publishing, update our
progress to date, and summarize where we intend to go with this journal.
Qadaffi's lesson
Thirty-five years ago, on September 1st, 1969, I was an
eleven year old boy living with my family in Benghazi,
Libya. That morning, I awoke to an eerie silence. The nor-
mally bustling traffic outside of our apartment in a busy
suburb of Benghazi was not to be heard. In fact, there was
to be little or no traffic for the next several days. History
will recount that day as the first day of Mohmmar
Qadaffi's bloodless coup d'etat, seizing power in Libya.
What I learned that September week in 1969 was that
access to and distribution of information tipped the fate
of a state. On that September day, there were in fact two
groups of army officers vying to overthrow the then enfee-
bled Libyan King Idris. Qadaffi, at the time only twenty-
seven years old, headed a small group of very junior offic-
ers. He, however, had a bold and swift strategy. His first
targets were not the dams, the power stations, the police
stations...; but the radio stations (in 1969 television had a
very minor penetrance in Libya) and newspapers. By dint
of controlling the airwaves and printing presses and by
freely distributing his information during time of chaos,
Qadaffi held sway over the minds and the sentiments of
the populace. He was thus able to pre-empt the efforts of
a larger competing group of more senior army officers.
What does Qadaffi's story have to do with Open Access
publishing? Imagine how the outcome might have been
different in 1969 if broadcast radio was not freely and
openly accessible by the masses but was an expensive sub-
scription service limited to a few. In that setting, and per-
haps in all settings, information that reaches a little
audience at a steep cost is information with little effect.
Retrovirology, freely and openly accessible by all
Curiously, the force that drives a coup d'etat is the same
that motivates scientists to publish (although I am not
suggesting that scientists are like Qadaffi). As scientists,
we want everyone who is interested to read what we have
done; and ideally we want that information to get to the
widest audience in the fastest, most informative, and least
expensive manner. Until now, ideal and reality were two
entirely different matters. Traditional publishing in print
journals reaches a limited audience, is slow, bulky, and
expensive. By its very nature (i.e. pages of paper are heavy
to mail and expensive to print), there is a real impetus on
the part of print publishers to restrict the space available
to authors. We are all too familiar with the results: abbre-
viated presentation of methods and text, the necessity to
"inadvertently" not cite many colleagues' publications,
and the ubiquitous use of microscopic figure panels that
provoke blurred vision and headaches. I daresay that
many after having read a short "letter" or a "brief
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definitive" report have been left scratching heads and
wondering how the experiments were done, where did the
vectors come from, and why many controls were defi-
nitely missing.
For the retrovirology community, Retrovirology  aims to
change such "reality". Retrovirology is published by Bio-
Med Central, an independent publisher committed to
ensuring immediate free access to peer-reviewed biomed-
ical research. Retrovirology is Open Access which means
that it is universally and freely available online to every-
one. You as the author retain copyright, and your paper is
guaranteed to be archived in at least one internationally
recognised repository [1]. More importantly, publishing
in Retrovirology is rapid. For example, a full research article
was reviewed and published in less than 20 days [2]; and
a review article was similarly processed in 8 days [3]. Ret-
rovirology  will also give you all the space and all the
colored prints (at no extra charge) to present your findings
informatively and attractively. If we don't publish your
paper, we will tell you honestly what is scientifically defi-
cient about your work. I promise not to obfuscate myself
using annoyingly belittling mantra that my editorial deci-
sion was guided by "intense competition for space".
Judge a book by its cover?
This is my second editorial for Retrovirology readers [4].
Retrovirology  has been publishing on-line now for 6
months. While a first editorial can speak of dreams and
aspirations, the burden of a second editorial is to demon-
strate results and progress. Aided by an international
cohort of extremely capable editors (Monsef Benkirane,
Ben Berkhout, Masahiro Fujii, Michael Lairmore, Andrew
Lever, and Mark Wainberg) and sixty editorial board
members [5], I am indeed encouraged and gratified by
Retrovirology's initial achievements. As of this writing, we
have published 22 papers. These are good papers; and
importantly, these papers are being widely-read. I can say
with some pride that half (11 out of 22; see Table 1) of our
published papers have been read more than 1,000 times
each. The remaining papers are not far behind; our most
recently published paper, barely 1 week on-line, has
already had more than 200 readers. Given that retrovirol-
ogy is a relatively small community of researchers, my per-
sonal experience of twenty years in this field tells me that
these are very respectable numbers.
Table 1: Access statistics for the top 11 Retrovirology articles.
Article Access Count
1 Early steps of retrovirus replicative cyclehttp://www.retrovirology.com/content/pdf/1742-4690-1-9.pdf Sébastien 
Nisole, Ali Saïb Retrovirology 2004, 1: 9
1890
2 Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and 
suitable for high-throughput evaluation of CCR5 and CXCR4 antagonistshttp://www.retrovirology.com/content/
pdf/1742-4690-1-2.pdf Katrien Princen, Sigrid Hatse, Kurt Vermeire, Erik De Clercq, Dominique Schols Retrovirology 2004, 
1: 2
1602
3 Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41http://
www.retrovirology.com/content/pdf/1742-4690-1-3.pdf Rogier W Sanders, Martijn M Dankers, Els Busser, Michael Caffrey, 
John P Moore, Ben Berkhout Retrovirology 2004, 1: 3
1332
4 Use of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies 
and ChIP-chip analysishttp://www.retrovirology.com/content/pdf/1742-4690-1-10.pdf Elodie Ghedin, Anne Pumfery, 
Cynthia de la Fuente, Karen Yao, Naomi Miller, Vincent Lacoste, John Quackenbush, Steven Jacobson, Fatah Kashanchi 
Retrovirology 2004, 1: 10
1313
5 Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort studyhttp://
www.retrovirology.com/content/pdf/1742-4690-1-4.pdf Jennie R Orland, Baoguang Wang, David J Wright, Catharie C 
Nass, George Garratty, James W Smith, Bruce Newman, Donna M Smith, Edward L Murphy, Retrovirology 2004, 1: 4
1209
6 Retrovirology and young Turks... http://www.retrovirology.com/content/pdf/1742-4690-1-1.pdf Kuan-Teh Jeang 
Retrovirology 2004, 1: 1
1140
7 HIV-1 gene expression: lessons from provirus and non-integrated DNAhttp://www.retrovirology.com/content/
pdf/1742-4690-1-13.pdf Yuntao Wu Retrovirology 2004, 1: 13
1103
8 Multi-faceted, multi-versatile microarray: simultaneous detection of many viruses and their expression 
profileshttp://www.retrovirology.com/content/pdf/1742-4690-1-11.pdf Biehuoy Shieh, Ching Li Retrovirology 2004, 1: 11
1097
9 Two discrete events, human T-cell leukemia virus type I Tax oncoprotein expression and a separate stress 
stimulus, are required for induction of apoptosis in T-cellshttp://www.retrovirology.com/content/pdf/1742-4690-
1-7.pdf Takefumi Kasai, Kuan-Teh Jeang Retrovirology 2004, 1: 7
1088
10 Apoptosis of uninfected cells induced by HIV envelope glycoproteinshttp://www.retrovirology.com/content/pdf/
1742-4690-1-12.pdf Barbara Ahr, Véronique Robert-Hebmann, Christian Devaux, Martine Biard-Piechaczyk Retrovirology 
2004, 1: 12
1076
11 HIV CTL escape: at what cost?http://www.retrovirology.com/content/pdf/1742-4690-1-8.pdf Stephen M Smith 
Retrovirology 2004, 1: 8
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Despite that many of you would argue to me that you
would rather publish in Cell, Science, and Nature rather
than Retrovirology. I wouldn't dispute you on that point.
On the other hand, I would ask you to pause and think
about a refrain that I am sure all of you have taught your
children, "Don't judge a book by its cover!" Please, don't
sell your own work short; and please don't belittle the
objectivity of your colleagues. If you have a wonderful
piece of work, do you truly need the cover of Cell to estab-
lish that point? On the other hand, if you have a horrible
study, do you think that hiding it behind the cover of
Nature  would fool many of your colleagues for long?
There was a time in the print age when display space on
reading room shelves was limited and perhaps justifiably
dominated by "the big three". Today, Retrovirology will get
your paper listed in PubMed within 48 hours of accept-
ance for publication. Anyone in this electronic era whose
reading habits are not guided by PubMed in one way or
another is probably someone who you may not care to
read your study. In short, Retrovirology will promise your
immediacy of publication and visibility for your work.
Your papers will be well-read by your colleagues. Beyond
that, I believe, and I think you do too, the impact of your
work should rest on its merits and not on our or any other
journal's cover.
Open Access is not free lunch
Besides teaching about book covers, I think the other con-
cept that we teach our children is that "There is no free
lunch!" At the end of the day, anything worth doing has a
price tag. I, my colleague editors, and all the editorial
board members at Retrovirology work for free for the jour-
nal. We can do this because we collect a salary elsewhere
doing research. On the other hand, we do have a dedi-
cated staff based at the publisher in London. No one
would question that the salaries for these professionals as
well as other publication costs must be borne. To fund
these costs, from October 1, 2004, authors of articles
accepted for publication will be asked to pay a single all-
inclusive article-processing charge (APC) of US$600;
there are no additional charges beyond this sum. Retrovi-
rology will not levy additional page or colour charges on
top of this fee. You are free to publish any number of col-
our figures and photographs, at no extra cost.
I support the need for APC, because without this Retrovi-
rology cannot be published. I think most of you will agree
based on your experience with other publishers that
US$600 is more than modest and reasonable. As a point
of comparison, the Public Library of Science has set up
two new Open Access journals, and has set their APCs at
US$1500, fully two and one-half times our charge, for
each accepted article [6]. Nonetheless, I realize that any
APC fee can present an unacceptable financial hardship
for some authors. These authors should feel free to contact
me in confidence, and I will consider fee-waiver requests
on a case-by-case basis.
In closing, let me thank those of you who have read, sub-
mitted and reviewed papers for Retrovirology. More than
anything else, Retrovirology is not my journal as much as it
is your journal. I welcome your advice, and I look forward
to hearing from you.
Abbreviations
APC = article-processing charge.
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